GABA trials recruiting now

2 registrations that name GABA as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.

Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.

Filter 2 registrations

Status

Phase

All 2 registrations

RecruitingNCT06864520

Evaluation of the Beneficial Effects of a Product Containing Γ-aminobutyric Acid (GABA) on Climacteric Syndrome Disorders

  • No phase
  • Ospedale Policlinico San Martino
  • About 112 people
  • Started Oct 25, 2023

In plain words A study of GABA in female participants of any age, run by Ospedale Policlinico San Martino. It plans to enroll about 112 people at 1 site, none in the US.

Who it lists and where

Who the trial lists, as registered

Lists female participants of any age. Conditions: Climacteric Symptoms; Hot Flashes.

  • Physiological or iatrogenic menopause (amenorrhea for at least 12 months or for 6 months with FSH ≥40 IU/L)
  • Greene Index value ≥ 15

The exclusion criteria are on the listing.

What it tests, as registered

GAMMA-AMINOBUTYRIC ACID - GABA; Placebo

Registered summary

The goal of this clinical trial is to learn if the food supplement based on GABA works to treat climateric symptoms. It will also learn about the safety of supplement based on GABA. The main question aims to answer: * Does food supplement based on GABA lower the climateric symptoms, such as hot flashes, sleep, disturbances, mood swings? * The supplement that will be administered is commonly available on the market and can be used without particular precautions. No important side effects are reported. The full summary is on the listing.

Where, as registered

No US site; Italy (1).

RecruitingNCT04144439

Effect of GABA on ADHD and Seizures in Children With Epilepsy.

  • Phase 4
  • Sherief Abd-Elsalam
  • About 30 people
  • Started Jul 1, 2018

In plain words A Phase 4 study of GABA in people 4 to 18, run by Sherief Abd-Elsalam. It plans to enroll about 30 people at 1 site, none in the US.

Who it lists and where

Who the trial lists, as registered

Lists people 4 to 18. Conditions: Epilepsy.

  • Epilepsy
  • ADHD

The exclusion criteria are on the listing.

What it tests, as registered

GABA

Registered summary

Effect of GABA on ADHD and seizures in Children with epilepsy.

Where, as registered

No US site; Egypt (1).

ClinicalTrials.gov lists 105 open registrations for this search, including ones where GABA is not a study arm or that are past the 2 we keep. Search them on ClinicalTrials.gov (opens in new tab).

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.